O'Neil Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.4M Sell
14,154
-65,524
-82% -$77.3M 6.28% 5
2026
Q2
$95.6M Buy
+79,678
New +$81.4M 21.37% 1
2026
Q1
– Sell
-40,251
Closed -$43.3M – 32
2025
Q4
$43.3M Buy
+40,251
New +$38.5M 14.88% 2
2025
Q2
– Sell
-300
Closed -$248K – 63
2025
Q1
$248K Buy
+300
New +$250K 0.47% 18
2024
Q4
– Sell
-3,680
Closed -$3.26M – 51
2024
Q3
$3.26M Sell
3,680
-3,356
-48% -$3.02M 0.83% 17
2024
Q2
$6.37M Buy
+7,036
New +$5.63M 3% 10
2022
Q4
– Sell
-1,671
Closed -$540K – 48
2022
Q3
$540K Buy
+1,671
New +$529K 2.14% 15

Other funds holding LLY

O'Neil Global Advisors's LLY Position: Q3 2026 in Review

O'Neil Global Advisors reduced its Eli Lilly (LLY) stake by 82% in Q3 2026, selling an estimated $77.3M and leaving 14,154 shares worth $16.4M. The position accounts for 6.28% of the portfolio, ranked #5.

O'Neil Global Advisors first reported a position in LLY in Q3 2022 and has held it in 7 quarters since. The position peaked at $95.6M in Q2 2026. 4,178 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • O'Neil Global Advisors held 14,154 shares of Eli Lilly worth $16.4M as of Q3 2026.
  • O'Neil Global Advisors sold 65,524 Eli Lilly shares in Q3 2026, an estimated $77.3M.
  • Eli Lilly made up 6.28% of O'Neil Global Advisors's portfolio in Q3 2026, its #5 holding.
  • O'Neil Global Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 7 quarters since.
  • O'Neil Global Advisors's Eli Lilly position peaked at $95.6M in Q2 2026.
  • 4,178 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on O'Neil Global Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.